BioWorld14d
Peptidream’s oral myostatin inhibitors show lean body mass preservation in obesity model
Peptidream Inc. has released promising results from preclinical testing of its oral myostatin inhibitors, administered in ...
pharmaphorum5y
Roche joins others in dropping myostatin inhibitor for DMD
The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned development of RG6206, a myostatin inhibitor. The Swiss group revealed the ...
Hosted on MSN11mon
Scholar Rock gets FDA nod to trial SMA drug with GLP-1ra in obesity
Scholar Rock will be initiating a Phase II trial of its spinal muscular atrophy pipeline drug apitegromab alongside a GLP-1 receptor agonist (GLP-1ra) in patients with obesity months after being ...
BioWorld14d
Peptidream’s oral myostatin inhibitors show lean body mass preservation in obesity model
Peptidream Inc. has released promising results from preclinical testing of its oral myostatin inhibitors, administered in combination with semaglutide, in a mouse model of obesity. Peptidream’s oral ...